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Abstract
Background: The purpose of this study was to test the hypothesis that menstruation is associated with
a higher concentration of endometrial cells in peritoneal fluid(PF) and with increased white and red blood
cell concentration in PF when compared to nonmenstrual phases of the cycle.
Methods: PF was obtained at laparoscopy from 107 women with endometriosis (n = 59) and controls
with a normal pelvis (n = 48) during the luteal (n = 46), follicular (n = 38) or menstrual (n = 23) phase of
the cycle. Endometriosis was classified according to the classification of the American Society for
Reproductive Medicine (rAFS into minimal (n = 25), mild(n = 20), moderate(n = 6) and severe(n = 8)
disease. Cell counts (leucocytes, erythrocytes, thrombocytes) were determined on a cell counter. In a
subset of 32 patients (13 controls and 19 women with endometriosis), PF was fixed, processed and
thinlayers were prepared and stained with Papanicolaou method and with immunocytochemistry using
monoclonal antibodies against cytokeratin 7(CK 7), CK 8/18, Ber-Ep4, vimentin, calretinin and CD68. Ber-
Ep4 is a marker for cells with epithelial origin (in some cases for mesothelial cells as well). CD68 is specific
for cells from monocyte/macrophage lineage; CK7 and CK8/18 are markers for both endometrial epithelial
and mesothelial cells, whereas calretinin and vimentin are markers for both endometrial stromal and
mesothelial cells.
Results: In comparison with the nonmenstrual phase of the cycle, analysis of PF during menstruation
showed an increased concentration of leucocytes (3.3 × 109/L vs 0.8 × 109/L, P = 0.03), erythrocytes (0.3
× 1012/L vs 0.02 × 1012/L, P = 0.006), hematocrit (0.03 L/L vs 0.003 L/L, P = 0.01) and hemoglobin (0.8 g/
dL vs 0.1 g/dL, P = 0.01). Mesothelial cells stained positively with CK7, CK8/18, vimentin, and calretinin.
Cells positive for Ber-Ep4 were not observed, except in 2 patients with endometriosis investigated during
menses. In all patients 50-98% of single cells were strongly positive for both vimentin and CD68.
Conclusion: When compared to nonmenstrual phases of the cycle, menstruation is associated with an
increased concentration of red and white blood cells in PF. However, the presence of EM cells that are
detectable by immunohistochemistry in PF is low during all phases of the cycle, including menstruation.
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Background
Endometriosis is characterized by the presence and
growth of endometrial-like tissue outside the uterus and
occurs in 10% of women of reproductive age. The patho-
genesis of endometriosis can to a certain extent be
explained by retrograde menstruation of endometrial tis-
sue sloughed through patent fallopian tubes into the peri-
toneal cavity [1]. However, it has never been shown that
the prevalence of endometrial (EM) cells in peritoneal
fluid (PF) is higher in women with endometriosis than in
controls during menstruation. In fact, the cytology of ret-
rograde menstruation has never been studied in depth.
Based on epidemiological and experimental data, it can
be hypothesized that the quantity of retrograde menstru-
ation and the consecutively flushed endometrial cells play
an important role in the development of endometriosis
[2]. In previous research, retrograde menstruation,
defined as red stained PF [3], has been observed during
culdoscopy in 50% [4], and during laparoscopy in 70-
90% of patients at the time of menstruation [5]. However,
the presence of red blood cells in PF is not a proof of the
presence of viable EM cells at the time of menstruation.
Furthermore, in most studies the identification of PF EM
cells has been limited to classical histological analsyis of
cell clumps present in PF [6,7]. Not surprisingly, the pres-
ence of endometrial cells in PF has been reported to vary
between 0 - 59% [8]. Using more objective immunocyto-
chemical methods, some investigators [9] reported that PF
contains single epithelial cells, rather than endometrial
tissue fragments, in women with patent tubes and that
these cells might be of endometrial origin. However, there
is no evidence that the EM cell concentration in PF is
higher during menstruation than in other phases of the
menstrual cycle.
Erythrocytes represent a part of the cell population in PF
whichalso contains other free floating cells like macro-
phages, mesothelial cells, lymphocytes, eosinophil and
mast cells. Several studies show that there is an increase in
erythrocyte count and consecutively in hemoglobin con-
tent in the peritoneal fluid of women with peritoneal
endometriosis when compared with controls with a nor-
mal pelvis [10]. Hemoglobin overload might have numer-
ous cytotoxic effects in the peritoneal environment
[11,12]. Its nonprotein moeity, heme, and its ferrous iron
core are known as pro-oxidant and proinflammatory mol-
ecules [13] and might be involved in the pathogenesis of
endometriosis through several mechanisms including
induction of oxidative stress, stimulation of cell adhesion,
and cytokine production by macrophages [10]. However,
it is not known if the PF concentration of red blood cells
and hemoglobin is higher during menstruation than dur-
ing nonmenstrual phases of the cycle. Endometriosis is
associated with a state of subclinical peritoneal inflamma-
tion, marked by an increased PF volume, increased PF
white blood cell concentration (especially macrophages
with increased activation status), and increased inflam-
matory cytokines, growth factors, and angiogenesis-pro-
moting substances [5,14-16]. Moreover, it has been
reported in baboons that subclinical peritoneal inflam-
mation occurs both during menstruation and after
intrapelvic injection of endometrium and both the inci-
dence and recurrence of retrograde menstruation is
increased in baboons with spontaneous endometriosis
when compared to healthy controls [17-19]. However, it
is not known if the PF concentration of white blood cells
is higher during menstruation than during nonmenstrual
phases of the cycle.
The lack of knowledge regarding potential differences in
the presence and distribution of PF cell populations dur-
ing menstruation between women with and without
endometriosis is a major obstacle with respect to the
validity of the Sampson hypothesis. The aim of our study
was to test the hypothesis that menstruation is associated
with a higher PF concentration of RBCs, WBCs and EM
cells when compared to nonmenstrual phases of the cycle.
Methods
Patients and sample collection
Our study protocol was approved by the Institutional Eth-
ical and Review Board of Gasthuisberg University Hospi-
tal, KU Leuven for the protection of human subjects.
Informed consent was obtained from all patients before
entry into this study. A diagnostic laparoscopy for investi-
gation of pelvic pain and/or infertility was performed in
107 reproductive age women (range 22-44 years, demo-
graphic data in Table 1). A normal pelvis was observed in
48 women. Endometriosis was found in 59 women and
was classified (American Society for Reproductive Medi-
cine, 1997) into minimal (n = 25), mild (n = 20), moder-
ate (n = 6) and severe (n = 8) disease. Endometriosis was
confirmed histologically in all patients (n = 59). All 107
patients had patent tubes. Samples of PF were collected
during the luteal (n = 46), follicular (n = 38) or menstrual
(n = 23) phase of the cycle. The PF was aspirated from the
pouch of Douglas before any surgical manipulation was
started and immediatelly processed. Special precaution
was taken to avoid blood or other fluid (saline, methylene
blue dye) contamination. Peritoneal washing was not per-
formed. In all PF samples the colour was noted and
divided in the following categories: clear, light yellow, yel-
low, orange, pink, light red, red, dark red.
In the first 32 patients included in our study, PF cells were
used for a detailed cytological analysis using Papanicolau
staining and immunocytochemical analysis. These 32
patients included 13 controls and 19 patients with mini-
mal (n = 8), mild (n = 5), moderate (n = 2) or severe (n =Reproductive Biology and Endocrinology 2009, 7:123 http://www.rbej.com/content/7/1/123
Page 3 of 7
(page number not for citation purposes)
4) endometriosis. In these 32 patients, PF samples were
collected during the luteal (n = 20), the follicular (n = 5)
or the menstrual (n = 7) phase of the cycle.
Cell counts
Cell counts (leucocytes, erythrocytes) were determined on
a Symex SE 9500 cell counter (Sysmex Co., Kobe, Japan).
Leucocyte counts below 0.6 × 109/L were redone by the
counting chamber method (Nageotte counting chamber,
Marienfeld Laboratory Glassware, Lauda-Königshofen,
Germany).
Immunocytochemistry
PF specimens were centrifuged for 10 minutes at 3000
rpm. The pellet was processed and fixed with CytoRich
(Becton Dickinson, Franklin Lakes, NJ. USA) then one
thin-layer (Papanicolau stain) was prepared with Prep-
Stain (Becton Dickinson, Franklin Lakes, NJ. USA).
All PF samples underwent both Papanicolau and immu-
nocytochemical staining with monoclonal antibodies
against CK 7 (1:100; Dako, Glostrup Denmark), CK 8/18
(1:20; Novocastra, Newcastle upon Tyne, UK), Ber-Ep4
(1:200; Dako, Glostrup Denmark), vimentin (1:100;
Dako, Glostrup Denmark), calretinin (1:2000; Swant,
Bellinzona, Switzerland) and CD68 (1:10; Kp1, Dako,
Glostrup Denmark).
These antibodies were selected since they are commonly
used in effusion cytology and they are relevant to identify
endometrial epithelial or stromal cells, mesothelial cells
and macrophages in PF. Ber-Ep4 is a marker for cells with
epithelial (in some cases mesothelial) origin. CD68 is spe-
cific for cells from monocyte/macrophage lineage, CK7
and CK8/18 are markers for both endometrial epithelial
and mesothelial cells, whereas calretinin and vimentin are
markers for both endometrial stromal and mesothelial
cells (Tables 2 and 3). Immunocytochemistry was done
according to our routinely used protocol with respect to
the dilution of the primary antibody, application of the
heat-induced epitope retrieval and visualization of the
antibody complexes through Envision-HRP with DAB
(Dako, Glostrup, Denmark). Slides prepared by the Prep-
Stain method were evaluated by an experienced
cytopathologist (MD).
Statistical analysis
Numerical data were analysed using MS Office Excel (ver-
sion 6.0; Microsoft Corporation, Redmond, WA, USA).
Kolomogorov-Smirnov/Lilliefors and Shapiro-Wilks test
was used to test normality to determine whether paramet-
Table 1: Demographic Characteristics of the Study Population (n = 107)
Endometriosis (n = 59) Controls (n = 48)
Age (years, mean ± SD) 31.76 ± 3.71 28.27 ± 3.18
Duration of infertility (years, mean ± SD) 2.67 ± 2.06 2.13 ± 1.12
Primary/secondary infertility [n(%)] 39(66.1)/20(33.9) 30(62.5)/18(37.5)
Concurrent medication [n(%)] 2(3.38) 0
Phase of the menstrual cycle [n(%)]
Menstrual 18(78.26) 5(21.74)
Nonmenstrual total 38(45.23) 46(54.77)
Follicular 22(26.19) 16(19.04)
Luteal 16(19.04) 30(35.73)
Indication for surgery [n(%)]
Infertility 58(98.3) 45(93.75)
Pelvic pain 1(1.71) 3(6.25)
Table 2: Cell Counts in Menstrual vs. Nonmenstrual Phase of Cycle
Menstrual phase (n = 23) mean ± SD Nonmenstrual phase (n = 84) mean ± SD P value
Leucocytes × 109/L 3.3 ± 1.1 0.8 ± 0.5 0.03
Granulocytes
Basophilic × 109/L 0.2 ± 0.08 0.04 ± 0.02 0.002
Eosinophilic × 109/L 0.1 ± 0.09 0.04 ± 0.03 0.09
Erythrocytes × 1012/L 0.3 ± 0.2 0.02 ± 0.01 0.006
Haematocrit L/L* 0.03 ± 0.01 0.003 ± 0.02 0.01
Haemoglobin g/dL 0.8 ± 0.7 0.1 ± 0.17 0.01
* calculated valuesReproductive Biology and Endocrinology 2009, 7:123 http://www.rbej.com/content/7/1/123
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ric or non-parametric tests were to be used in further anal-
yses. For statistical analyses, Mann-Whitney and Fisher
exact tests were performed. Statistical calculations were
performed by using the GraphPad Prism version 5. 00 for
Windows, (GraphPad Software, San Diego California
USA), and P ≤ 0.05 was considered significant.
Results
In comparison with the nonmenstrual phase of the cycle
(n = 84), analysis of PF during menstruation (n = 23)
showed a 3 fold increased concentration of leucocytes, a 4
fold increase in the concentration of basophilic granulo-
cytes, and a 13, 10 and 8 fold increase in the concentra-
tion of erythrocytes, hematocrit and hemoglobin,
respectively (Table 2). Morphological evaluation of the
Pap-stained specimens showed that the prevalence in PF
of single cells with an endometrial phenotype was low
and comparable during menstruation (1/7), follicular
phase (1/5), and luteal phase (2/20 including one case of
single cells and one case of a group of cells). In contrast,
mesothelial cells and histiocytes were present in all PF
samples.
Mesothelial cells stained positively with CK7, CK8/18,
vimentin, calretinin and sometimes weakly with CD68.
Cells positive for epithelial marker Ber-Ep4 were not
observed, except in two patients investigated during men-
ses who had a few positive cells. In 9/31 patients, the sin-
gle cell population contained 10-50% cells with very
weak, probably nonspecific staining for calretinin. In all
patients 50-98% of single cells were strongly positive for
both vimentin and CD68. Most of the single cells present
in PF were histiocytes or belonged to the monocyte/mac-
rophage lineage. The prevalence of mesothelial cells and
macrophages staining positively for the antibodies tested
(Table 4) was comparable between menstrual and non-
menstrual phases of the cycle and between patients with
and without endometriosis.
Discussion
To the best of our knowledge, our study presents for the
first time evidence that menstruation in women is associ-
ated with increased PF concentration of leucocytes and
erythrocytes when compared to nonmenstrual phases of
the cycle. Our data indicate that menstruation is associ-
ated with pelvic inflammation and are in agreement with
our previous observation in nonhuman primates demon-
strating higher levels of white blood cells in PF during
menstruation [2].
Our data also show that menstruation is associated with a
significant increase in erythrocyte count and consecutively
in free hemoglobin content in PF, and provide a quantita-
tive basis for the concept of retrograde menstruation.
Hemoglobin accumulation in the peritoneal cavity may
be a consequence of increased influx caused by red blood
cell degradation, from retrograde menstrual reflux and/or
a deficiency in the hemoglobin inactivating system [12]
and may be involved in the pathogenesis of endometrio-
sis [10].
In the context of the pathogenesis of endometriosis, retro-
grade menstruation has to be diagnosed not only as an
increased presence of erythrocytes in PF but also as the
presence of endometrial cells in PF. Nevertheless, many
investigators [20-23] have interpreted the presence of red
stained PF at the time of menstruation as sufficient evi-
dence for retrograde menstruation of EM cells. However,
it is well known that red-stained PF can be observed not
only during menstruation but also during the first 5 days
after ovulation [24] and during other phases of the cycle
[23,25] and that there is only a weak correlation between
the presence of endometrial cells and the color of PF [26].
In our study, we could not confirm the hypothesis that the
prevalence and/or quantity of EM cells in PF is increased
in women with endometriosis (when compared to con-
trols) and increased during menstruation (when com-
pared to nonmenstrual phases of the cycle). Scientific
evidence related to this hypothesis is controversial for sev-
eral reasons.
Firstly, all studies addressing PF cytology are limited by
small sample size, variable and sometimes unspecified
Table 3: Immunocytological markers for different cell populations present in peritoneal fluid
Marker Endometrial epithelial/
glandular cells
Endometrial stromal 
cells
Mesothelial cells Macrophages NK cells Lymphocytes
Ber Ep4 +- - - - -
Vimentin -+ + - - -
Calretinin -+ + - - -
Cytokeratin7 +- + - - -
Cytokeratin8 +- + - - -
Cytokeratin18 +- + - - -
CD68 -- - / + + - -Reproductive Biology and Endocrinology 2009, 7:123 http://www.rbej.com/content/7/1/123
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phases of the cycle studied, subjective methods to define
or detect EM cells or tissue in PF, and prior flushing of
uterus and tubes via hysteroscopy before laparoscopic
aspiration of PF cells.
Secondly, most investigators have used Papanicolaou or
Giemsa staining to detect EM cells in PF and have consid-
ered clusters of cells in PF with positive staining to be EM
cells [23,26]. However, there is no proof that PF clusters
of cells represent EM cells, since they may also include
mesothelial cells or macrophages and hystiocytes. Indeed,
recent evidence [25] suggests that EM cells rarely aggluti-
nate in PF to become macroscopically visible tissue frag-
ments containing endometrial glands and stroma during
menstruation (in only 17% or 3/18 cases and similar in
women with (2/9) and women without (1/9) endometri-
osis) or during all combined phases of the cycle (in only
16% or 16/99 cases and similar in women with (13/65 or
20%) and women without (3-34 or 9%) endometriosis).
Thirdly, immunocytological identification of EM cells in
PF is not evident as reported in our study and in 3 papers
published by 3 others groups of investigators [9,25,27].
Comparison between these 4 studies is difficult since
native PF cells were analyzed in our study and in only one
other paper [9] whereas PF cell cultures were used in the 2
other reports [25,27]. It is possible that immunocytologi-
cal detection of EM cells is facilitated after cell culture
when compared to analysis of EM cells in native PF. In our
study the PrepStain method was used for the first time to
study the cytology of native PF in women with endometri-
Table 4: Prevalence of patients with PF cells stained positively by immunocytochemistry for 7 different cell markers among 32 patients 
with (endo, n = 19) or without (control, n = 13) endometriosis
Marker Endometrial epithelial/glandular cells Endometrial stromal cells Mesothelial cells Macrophages/Monocytes
Endo Contr Endo Contr Endo Contr Endo Contr
Ber Ep4
Total 2/19 0/13 0/19 0/13 0/19 0/13 0/19 0/13
Menstrual 2/5 0/2 0/5 0/2 0/5 0/2 0/5 0/2
Follicular 0/4 0/1 0/4 0/1 0/4 0/1 0/4 0/1
Luteal 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
Vimentin
Total 0/19 0/13 17/19 11/13 17/19 11/13 0/19 0/13
Menstrual 0/5 0/2 5/5 2/2 5/5 2/2 0/5 0/2
Follicular 0/4 0/1 4/4 1/1 4/4 1/1 0/4 0/1
Luteal 0/10 0/10 8/10 8/10 8/10 8/10 0/10 0/10
Calretinin
Total 0/19 0/13 11/19 9/13 11/19 9/13 0/19 0/13
Menstrual 0/5 0/2 4/5 1/2 4/5 1/2 0/5 0/2
Follicular 0/4 0/1 2/4 1/1 2/4 1/1 0/4 0/1
Luteal 0/10 0/10 5/10 7/13 5/10 7/10 0/10 0/10
Cytokeratin7
Total 10/19 6/13 0/19 0/13 10/19 6/13 0/19 0/13
Menstrual 3/5 2/2 0/5 0/2 3/5 2/2 0/5 0/2
Follicular 3/4 1/1 0/4 0/1 3/4 1/1 0/4 0/1
Luteal 4/10 3/10 0/10 0/10 4/10 3/10 0/10 0/10
Cytokeratin8
Total 4/19 3/13 0/19 0/13 4/19 3/13 0/19 0/13
Menstrual 1/5 0/2 0/5 0/2 1/5 0/2 0/5 0/2
Follicular 1/4 0/1 0/4 0/1 1/4 0/1 0/4 0/1
Luteal 2/10 3/10 0/10 0/10 2/10 3/10 0/10 0/10
Cytokeratin18
Total 4/19 3/13 0/19 0/13 4/19 3/13 0/19 0/13
Menstrual 1/5 0/2 0/5 0/2 1/5 0/2 0/5 0/2
Follicular 1/4 0/1 0/4 0/1 1/4 0/1 0/4 0/1
Luteal 2/10 3/10 0/10 0/10 2/10 3/10 0/10 0/10
CD68
Total 0/19 0/13 0/19 0/13 0/19 0/13 17/19 11/13
Menstrual 0/5 0/2 0/5 0/2 0/5 0/2 5/5 2/2
Follicular 0/4 0/1 0/4 0/1 0/4 0/1 4/4 1/1
Luteal 0/10 0/10 0/10 0/10 0/10 0/10 8/10 8/10
Endo = patients with endometriosis
Contr = patients with a normal pelvisReproductive Biology and Endocrinology 2009, 7:123 http://www.rbej.com/content/7/1/123
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osis. This liquid-based preparation technique is adequate
for the immunocytochemical study of numerous cell lines
in effusion specimens [28] since cells are transferred
directly into the liquid medium at the time of collection
and therefore the artefact of air-drying artifact, a culprit in
many limited or inadequate conventional smears, is pre-
vented. The results of our study are in line with a previ-
ously published immunocytological analysis of PF cells
[9] obtained during the early follicular phase from 8
women with endometriosis and 8 with a normal pelvis. In
that study [9] all PF samples except one contained cells
stained positively with monoclonal antibodies against
vimentin, cytokeratin 18 and 19, and 9 out of 16 PF sam-
ples contained cells that stained positively with mono-
clonal antibody BW495/36, an epithelial marker present
in endometrium and absent in peritoneal epithelium.
These data and our data are consistent with the interpreta-
tion that EM cells are present in PF from patients with pat-
ent fallopian tubes, and that their immunocytological
staining profile is not different between women with and
without endometriosis. However, among PF cells
obtained during the late follicular phase prior to uterine
flushing and cultured in vitro, other investigators could
not identify EM cells that were immunocytologically pos-
itive for cytokeratins 5/7/8/14/19, cytokeratin 7/18, epi-
thelial marker: BW495/36, HMFG 2, EM epithelial marker
NEND-3 or ovarian carcinoma related markers OV-TL3,
OV-TL10, OC-125 [27].
Fourthly, it is very difficult to identify with 100% certainty
specific PF cell types by specific immunocytological mark-
ers, since endometrial epithelial, endometrial stromal,
mesothelial cells and macrophages all stain positively for
more than one marker (Table 3). For example, it was
impossible to make a firm distinction in our study
between endometrial stromal cells and mesothelial cells,
since both cell types stained positively for vimentin and
calretinin. It can be argued that our study was limited by
the fact that endometrial stromal cell marker CD10 was
not used, but the problem is that also other cell types stain
positively for CD10, most importantly cervical stromal
cells [29] and other cell types (normal renal tubular and
glomerular cells, renal carcinoma, hepatocellular carci-
noma lymphoid cells, mesonephric tumors, and acute
lymphoblastic leukemia and lymphoma).
Taking together the evidence from our study and other
studies, it is remarkable to conclude that even today there
is no sound scientific evidence based on the analysis of PF
fluid cells that retrograde menstruation is associated with
the increased presence of endometrial cells in PF. Recent
in vitro evidence demonstrating that attachment in vitro
of endometrial cells on mesothelial cells occurs within 1
hour [30] supports the possible explanation that EM cells,
refluxed via the Fallopian tube during menstruation into
the pelvic cavity, attach in a very short time to the perito-
neal wall before they are detectable as free floating cells or
clusters in PF. However, it is also possible that endometri-
osis does not (only) arise from retrograde menstruation,
but may also be a consequence of mesothelial metaplasia
induced by menstruation or other factors. In support of
this metaplasia/induction theory, peritoneal endometrio-
sis lesions appear to contain only stromal endometriosis
in 45% of the cases, and stromal endometriosis can be
found in about 7% of macroscopically normal perito-
neum [31].
Conclusion
The results of our study demonstrate for the first time that
menstruation in women is associated with an increased PF
concentration of leucocytes, erythrocytes and hemoglobin
when compared to nonmenstrual phases of the cycle, sup-
porting the concept of retrograde menstruation. An
increased PF concentration of PF endometrial cells was
not observed during menstruation when compared to
nonmenstrual phases of the cycle.
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